Drug Pricing Policy Making – Impactful or Not?
November 1, 2018
No Comments
In May 2018 U.S. President Donald Trump predicted that pharmaceutical manufacturers would “announce voluntary massive drops in prices” after introducing his “American Patients First” 44 page blueprint for reforming drug pricing. This blueprint includes a